TMEM16F is linked to Scott syndrome, a rare congenital bleeding disorder14, where activated platelets from individuals with loss-of-function TMEM16F mutations fail to execute plasma membrane phosphatidylserine scrambling necessary for thrombin production and for the release of EVs that facilitate coagulation25,26. Here, ANO6 is linked to Scott syndrome.